HIV-2 RNA DETECTION BY REAL TIME PCR (QUALITATIVE)

The HIV-2 RNA Detection by Real Time PCR (Qualitative) is a molecular laboratory test that detects the presence or absence of HIV‑2 viral RNA in a patient’s blood using real‑time polymerase chain reaction. Unlike antibody or antigen screening, this qualitative PCR identifies viral genetic material directly, enabling earlier detection of infection during the window period and in cases where serology is inconclusive.

This test is primarily used for early diagnosis after suspected exposure, to resolve indeterminate or discordant HIV test results, and for testing infants born to mothers with suspected or confirmed HIV‑2. Note that this qualitative assay confirms presence/absence of HIV‑2 RNA and is not intended for quantitative viral load monitoring; patients taking antiretroviral therapy (ART) should inform the collecting team as treatment can suppress detectable RNA. Home sample collection across Dubai is available with confidential, lab‑grade processing and secure reporting consistent with UAE healthcare standards.

• HIV‑2 RNA (Qualitative Detection)
• Internal Amplification Control
• Assay Validity / Positive & Negative Controls
• Specimen Type: EDTA plasma (RNA integrity assessed)

• Following a recent high‑risk exposure for early detection (before seroconversion)
• When experiencing acute retroviral symptoms (fever, rash, sore throat, lymphadenopathy)
• If HIV antibody/antigen tests are indeterminate or give discordant results
• Testing infants born to mothers with suspected or confirmed HIV‑2
• When confirming HIV‑2 infection prior to specialist referral or treatment decisions

• Early detection of HIV‑2 infection before antibodies are detectable
• High analytical sensitivity and specificity for HIV‑2 RNA
• Confidential, lab‑grade testing with convenient at‑home sample collection in Dubai
• Useful for resolving indeterminate serology and for neonatal diagnostic use
• Secure results delivery and guidance for follow‑up with UAE healthcare providers

• At‑home venous blood collection by a trained phlebotomist (EDTA tube for plasma)
• Inform the team if you are on antiretroviral therapy (ART) or taking PrEP/PEP
• Valid ID and consent required; parental/guardian consent for minors
• Ensure the collector is informed of recent sample‑affecting factors (eg. recent transfusion)